Drug Database
Back to search

Ireland· IE-PA-EU/1/20/1526/002

TUKYSA 150 mg film-coated tablets

A antineoplastic agents product containing tucatinib, registered in Ireland by Pfizer Europe MA EEIG. The same ATC class is registered in 6 of our 19 countries.

ATC L01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTUKYSA 150 mg film-coated tabletsATCL01REGISTER NO.IE-PA-EU/1/20/1526/002PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tucatinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tucatinib is registered in 6 of 19 countries.

Countries holding a registration under ATC L01 (antineoplastic agents), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose
Search tucatinib products by name

Tucatinib · ATC L01

6 / 19 countries

  • Canada
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Tucatinib
Manufacturer
Pfizer Europe MA EEIG
Country
Ireland (IE)
ATC code
L01
ATC class
ANTINEOPLASTIC AGENTS
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/20/1526/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tucatinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tucatinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tukysa
  • Liechtenstein · Tukysa
  • Norway · Tukysa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3a977986-b7c3-43ab-a863-7b7a59ffd9a1
GET /v1/drugs/3a977986-b7c3-43ab-a863-7b7a59ffd9a1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01"
  ],
  "strength": null,
  "pa_number": "EU/1/20/1526/002",
  "substances": [
    "Tucatinib"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "11/02/2021",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about tucatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console